Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

ED arrests Himachal Assistant Drug Controller in corruption case Pharma News

ED arrests Himachal Assistant Drug Controller in corruption case

  • 13 October 2025
  • 2 weeks ago

Tamil Nadu cancels licence of Sresan Pharma, orders shutdown Pharma News

Tamil Nadu cancels licence of Sresan Pharma, orders shutdown

  • 13 October 2025
  • 2 weeks ago

Natco Pharma to buy significant stakes in South African Drugmaker Adcock Ingram Pharma News

Natco Pharma to buy significant stakes in South African Drugmaker Adcock Ingram

  • 13 October 2025
  • 2 weeks ago

Sun Pharma Wins Interim Relief in NAXDOM Trademark Row, Delhi HC Bars Alenvision's NEXADOM Drug Pharma News

Sun Pharma Wins Interim Relief in NAXDOM Trademark Row, Delhi HC Bars Alenvision's NEXADOM Drug

  • 13 October 2025
  • 2 weeks ago

Biocon gets 1 USFDA observation for Cranbury site Pharma News

Biocon gets 1 USFDA observation for Cranbury site

  • 13 October 2025
  • 2 weeks ago

Zydus, Dr Reddy's recall products in US over manufacturing issues Pharma News

Zydus, Dr Reddy's recall products in US over manufacturing issues

  • 13 October 2025
  • 2 weeks ago

Indore pharma unit under fire as inspection flags 216 lapses Pharma News

Indore pharma unit under fire as inspection flags 216 lapses

  • 13 October 2025
  • 2 weeks ago

Lupin gets 1 USFDA observation for Somerset facility Pharma News

Lupin gets 1 USFDA observation for Somerset facility

  • 12 October 2025
  • 2 weeks ago

Ongoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma Firms, DCGI Pharma News

Ongoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma Firms, DCGI

  • 12 October 2025
  • 3 weeks ago

SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar Pharma News

SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar

  • 12 October 2025
  • 3 weeks ago

Recent News

Himachal notifies Resident doctor policy 2025

  • 02 November, 2025

Pfizer files lawsuit against Metsera, its Director...

  • 02 November, 2025

Health Ministry achieves 3 Guinness World Records...

  • 02 November, 2025

Roche gets CE mark for Elecsys Dengue Ag test to d...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.